Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia

Skeletal Muscle

Volumn 5, Issue 1, 2015, Pages

  Duddy, William ^a,b   Duguez, Stephanie ^a,b   Johnston, Helen ^a   Cohen, Tatiana V ^a,c   Phadke, Aditi ^a   Gordish Dressman, Heather ^a   Nagaraju, Kanneboyina ^a   Gnocchi, Viola ^a   Low, SiewHui ^d   Partridge, Terence ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c KENNEDY KRIEGER INSTITUTE   (United States)

^d GEOPHYSICAL LABORATORY   (United States)

Author keywords

Hyperplasia; Hypertrophy; Hypotrophy; Muscle regeneration; Muscular dystrophy

Indexed keywords

EID: 84938363881     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/s13395-015-0041-y     Document Type: Article

References (75)

1. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A. 1984;81:1189-92.
2. Dangain J, Vrbova G. Muscle development in mdx mutant mice. Muscle Nerve. 1984;7:700-4.
3. Tanabe Y, Esaki K, Nomura T. Skeletal muscle pathology in X chromosomelinked muscular dystrophy (mdx) mouse. Acta Neuropathol. 1986;69:91-5.
4. Partridge TA. Animal models of muscular dystrophy-what can they teach us? Neuropathol Appl Neurobiol. 1991;17:353-63.
5. Harris JB, Slater CR. Animal models of muscular dystrophy. Br Med Bull. 1980;36:193-7.
6. Hoffman EP, Brown Jr RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919-28.
7. Partridge TA. The mdx mouse model as a surrogate for Duchenne muscular dystrophy. FEBS J. 2013;280:4177-86.
8. Zhao P, Hoffman EP. Embryonic myogenesis pathways in muscle regeneration. Dev Dyn. 2004;229:380-92.
9. Tseng BS, Zhao P, Pattison JS, Gordon SE, Granchelli JA, Madsen RW, et al. Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J Appl Physiol (1985). 2002;93:537-45.
10. Chen YW, Zhao P, Borup R, Hoffman EP. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol. 2000;151:1321-36.
11. Duddy WJ, Cohen T, Duguez S, Partridge TA. The isolated muscle fibre as a model of disuse atrophy: characterization using PhAct, a method to quantify f-actin. Exp Cell Res. 2011;317:1979-93.
12. Gnocchi VF, White RB, Ono Y, Ellis JA, Zammit PS. Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells. PLoS One. 2009;4:e5205.
13. White RB, Bierinx AS, Gnocchi VF, Zammit PS. Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev Biol. 2010;10:21.
14. Coulton GR, Curtin NA, Morgan JE, Partridge TA. The mdx mouse skeletal muscle myopathy: II. Contractile properties. Neuropathol Appl Neurobiol. 1988;14:299-314.
15. Duguez S, Duddy W, Johnston H, Laine J, Le Bihan MC, Brown KJ, et al. Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion. Cell Mol Life Sci. 2013;70:2159-74.
16. Coulton GR, Morgan JE, Partridge TA, Sloper JC. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol. 1988;14:53-70.
17. Bockhold K, Rosenblatt J, Partridge T. Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibres. Muscle Nerve. 1998;21:173-83.
18. Pichavant C, Pavlath GK. Incidence and severity of myofiber branching with regeneration and aging. Skelet Muscle. 2014;4:9.
19. Faber RM, Hall JK, Chamberlain JS, Banks GB. Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice. Skelet Muscle. 2014;4:10.
20. Pastoret C, Sebille A. Age-related differences in regeneration of dystrophic (MDX) and normal muscle in the mouse. Muscle Nerve. 1995;18:1147-54.
21. Carnwath JW, Shotton DM. Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci. 1987;80:39-54.
22. Merrick D, Stadler LK, Larner D, Smith J. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation. Dis Model Mech. 2009;2:374-88.
23. Brohl D, Vasyutina E, Czajkowski MT, Griger J, Rassek C, Rahn HP, et al. Colonization of the satellite cell niche by skeletal muscle progenitor cells depends on Notch signals. Dev Cell. 2012;23:469-81.
24. Sunada Y, Campbell KP. Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscle. Curr Opin Neurol. 1995;8:379-84.
25. Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, et al. Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Mol Cell Proteomics. 2013;12:1061-73.
26. Radley-Crabb HG, Marini JC, Sosa HA, Castillo LI, Grounds MD, Fiorotto ML. Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of Duchenne muscular dystrophy. PLoS One. 2014;9, e89277.
27. Jahnke VE, Van Der Meulen JH, Johnston HK, Ghimbovschi S, Partridge T, Hoffman EP, et al. Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet Muscle. 2012;2:16.
28. Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet. 2009;18:482-96.
29. Neal A, Boldrin L, Morgan JE. The satellite cell in male and female, developing and adult mouse muscle: distinct stem cells for growth and regeneration. PLoS One. 2012;7, e37950.
30. Cheek DB. Human growth - methods of approach. Aust Paediatr J. 1977;13:77-87.
31. Cheek DB, Petrucco OM, Gillespie A, Ness D, Green RC. Muscle cell growth and the distribution of water and electrolyte in human pregnancy. Early Hum Dev. 1985;11:293-5.
32. Dadgar S, Wang Z, Johnston H, Kesari A, Nagaraju K, Chen Y-W, et al. Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy. J Cell Biol. 2014;207:139-58.
33. Kornegay JN, Childers MK, Bogan DJ, Bogan JR, Nghiem P, Wang J, et al. The paradox of muscle hypertrophy in muscular dystrophy. Phys Med Rehabil Clin N Am. 2012;23:149-72.
34. Pearce GW, Pearce JMS, Walton JN. The Duchenne type muscular dystrophy: histopathological studies of the carrier state. Brain. 1966;89:109-20.
35. Kornegay JN, Cundiff DD, Bogan DJ, Bogan JR, Okamura CS. The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy. Neuromuscul Disord. 2003;13:493-500.
36. Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Grange RW. Golden retriever muscular dystrophy (GRMD): developing and maintaining a colony and physiological functional measurements. Methods Mol Biol. 2011;709:105-23.
37. Pastoret C, Sebille A. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci. 1995;4548:1-9.
38. Anderson JE, Bressler BH, Ovalle WK. Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J Muscle Res Cell Motil. 1988;9:499-515.
39. Anderson JE, Ovalle WK, Bressler BH. Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat Rec. 1987;219:243-57.
40. Boldrin L, Zammit PS, Morgan JE. Satellite cells from dystrophic muscle retain regenerative capacity. Stem Cell Res. 2014;14:20-9.
41. Collins CA, Zammit PS, Ruiz AP, Morgan JE, Partridge TA. A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells. 2007;25:885-94.
42. Grounds MD. Therapies for sarcopenia and regeneration of old skeletal muscles: more a case of old tissue architecture than old stem cells. Bioarchitecture. 2014;4:81-7.
43. Wang YX, Bentzinger CF, Rudnicki MA. Treating muscular dystrophy by stimulating intrinsic repair. Regen Med. 2013;8:237-40.
44. Mozzetta C, Consalvi S, Saccone V, Tierney M, Diamantini A, Mitchell KJ, et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old mdx mice. EMBO Mol Med. 2013;5:626-39.
45. Gibson MC, Schultz E. Age related differences in absolute numbers of skeletal muscle satellite cells. Muscle Nerve. 1983;6:574-80.
46. Le Grand F, Jones AE, Seale V, Scime A, Rudnicki MA. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell. 2009;4:535-47.
47. Kuang S, Gillespie MA, Rudnicki MA. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell. 2008;2:22-31.
48. Shinin V, Gayraud-Morel B, Gomes D, Tajbakhsh S. Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat Cell Biol. 2006;8:677-87.
49. Conboy MJ, Karasov AO, Rando TA. High incidence of non-random template strand segregation and asymmetric fate determination in dividing stem cells and their progeny. PLoS Biol. 2007;5, e102.
50. Rando TA. The immortal strand hypothesis: segregation and reconstruction. Cell. 2007;129:1239-42.
51. Webster C, Blau HM. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat Cel Mol Genetics. 1990;16:557-65.
52. Webster C, Filippi G, Rinaldi A, Mastropaolo C, Tondi M, Siniscalco M, et al. The myoblast defect identified in Duchenne muscular dystrophy is not a primary expression of the DMD mutation. Clonal analysis of myoblasts from five double heterozygotes for two X-linked loci: DMD and G6PD. Hum Genet. 1986;74:74-80.
53. Lipton BH. Skeletal muscle regeneration in muscular dystrophy. In: Mauro A, editor. Muscle regeneration. New York: Raven; 1979. p. 31-40.
54. Grounds MD, Yablonka-Reuveni Z. Molecular and cell biology of skeletal muscle regeneration. Mol Cell Biol Hum Dis Ser. 1993;3:210-56.
55. Decary S, Hamida CB, Mouly V, Barbet JP, Hentati F, Butler-Browne GS. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul Disord. 2000;10:113-20.
56. Renault V, Thornell LE, Eriksson PO, Butler-Browne G, Mouly V, Thorne LE. Regenerative potential of human skeletal muscle during aging. Aging Cell. 2002;1:132-9.
57. Blau HM, Webster C, Pavlath GK, Chiu CP. Evidence for defective myoblasts in Duchenne muscular dystrophy. Adv Exp Med Biol. 1985;182:85-110.
58. Blau HM, Webster C, Pavlath GK. Defective myoblasts identified in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 1983;80:4856-60.
59. Chang NC, Rudnicki MA. Satellite cells: the architects of skeletal muscle. Curr Top Dev Biol. 2014;107:161-81.
60. Kottlors M, Kirschner J. Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res. 2010;340:541-8.
61. Watkins SC, Cullen MJ. A quantitative study of myonuclear and satellite cell nuclear size in Duchenne's muscular dystrophy, polymyositis and normal human skeletal muscle. Anat Rec. 1988;222:6-11.
62. Maier F, Bornemann A. Comparison of the muscle fiber diameter and satellite cell frequency in human muscle biopsies. Muscle Nerve. 1999;22:578-83.
63. Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell. 2010;142:1059-71.
64. Pagel CN, Partridge TA. Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation. J Neurol Sci. 1999;164:103-16.
65. Wakeford S, Watt DJ, Partridge TA. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve. 1991;14:42-50.
66. Wernig A, Irintchev A, Weisshaupt P. Muscle injury, cross-sectional area and fibre type distribution in mouse soleus after intermittent wheel-running. J Physiol. 1990;428:639-52.
67. Partridge TA, Morgan JE. Multiple insights from myogenic cell transplants. Hum Gene Ther. 2014;25:404-5.
68. Blaveri K, Heslop L, Yu DS, Rosenblatt JD, Gross JG, Partridge TA, et al. Patterns of repair of dystrophic mouse muscle: studies on isolated fibers. Dev Dyn. 1999;216:244-56.
69. Chan S, Head SI. The role of branched fibres in the pathogenesis of Duchenne muscular dystrophy. Exp Physiol. 2011;96:564-71.
70. Head SI. Branched fibres in old dystrophic mdx muscle are associated with mechanical weakening of the sarcolemma, abnormal Ca2+ transients and a breakdown of Ca2+ homeostasis during fatigue. Exp Physiol. 2010;95:641-56.
71. Chan S, Head SI, Morley JW. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. Am J Physiol Cell Physiol. 2007;293:C985-92.
72. Metzger T, Gache V, Xu M, Cadot B, Folker ES, Richardson BE, et al. MAP and kinesin-dependent nuclear positioning is required for skeletal muscle function. Nature. 2012;484:120-4.
73. Qaisar R, Larsson L. What determines myonuclear domain size? Indian J Physiol Pharmacol. 2014;58:1-12.
74. Hernandez-Caballero E, Herrera-Gonzalez NE, Salamanca-Gomez F, Arenas-Aranda DJ. Role of telomere length in subtelomeric gene expression and its possible relation to cellular senescence. BMB Rep. 2009;42:747-51.
75. Lackner DH, Hayashi MT, Cesare AJ, Karlseder J. A genomics approach identifies senescence-specific gene expression regulation. Aging Cell. 2014;13:946-50.